CClinicalTrials.gg
CompletedNCT03378245TeleNHUpdated Aug 16, 2021

Telemedicine-based, Multidisciplinary-team, Intervention to Reduce Unnecessary Hospitalizations

An interventional study of Behavioral modification and education on pharmacologic treatments. in Dementia Alzheimers and Disruptive Behavior, sponsored by Richard Ronan Murphy. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2021-08-16.

Sponsored by Richard Ronan Murphy · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Not applicable
Sex
All
01

Study summary

The purpose of this study is to investigate the use of telemedicine-based intervention at urban and rural skilled nursing facilities to recommend multidisciplinary dementia care to residents with dementia who are at risk for unnecessary hospitalization due behavioral or neuropsychiatric symptoms and/or complications as well as caregivers and facility staff. The multidisciplinary team is comprised of trained behavioral neurologists, social workers, advanced practice providers, primary medical team and nurse coordinators.

02

Conditions studied

  • Dementia Alzheimers
  • Disruptive Behavior
03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Dementia Care facility resident Problematic behavioral problems

Exclusion criteria

Exclusion Criteria:

None

04

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Enrollment
16 participants (actual)

Study arms

  • Experimental
    Telemedicine Intervention

    Multidisciplinary telemedicine education of staff and providers on best practices for behavioral modification as well as education on best practices for pharmacologic therapies.

    Behavioral: Behavioral modification and education on pharmacologic treatments.

Interventions

  • BehavioralBehavioral modification and education on pharmacologic treatments.

    Education and counseling of care-giving staff on behavioral modification strategies, as well as education about current standard of care best practices for pharmacologic interventions.

05

What researchers measure

Primary outcomes

  1. Change in the Neuropsychiatric Inventory (NPI) total score

    The NPI assesses 10 behavioral symptom domains, scoring is based on symptom frequency and severity. The total NPI score sums the products of frequency and severity scores for each domain. Higher scores indicate more behavioral disturbance

    Time frame: 6 months

Secondary outcomes

  1. Change in the Resource Utilization in Dementia - Formal Care (RUD-FOCA)

    The RUD-FOCA records the care time in three areas: activities of daily living (ADL), instrumental activities of daily living (IADL) and supervision.

    Time frame: 6 months

  2. Change in Quality of Life in Alzheimers Dementia (QoL-AD)

    13 quality of life items are rated on a four point scale, with 1 being poor and 4 being excellent. Total scores range from 13 to 52. It generally takes caregivers about 5 minutes to complete the measure.

    Time frame: 6 months.

06

Study locations

1 site
  • University of Kentucky
    Lexington, Kentucky 40536, United States
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03378245
Lead sponsor
Richard Ronan Murphy
Responsible party
Richard Ronan Murphy (Assistant Professor of Neurology, University of Kentucky) — Sponsor-investigator
First posted
Dec 19, 2017
Start date
Sep 2013
Primary completion
Jul 31, 2020
Completion
Jul 31, 2020
Last update
Aug 16, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion